Physician

John E Richards, M.D.

According to 2025 Medicare claims, John Richards, M.D. (NPI: 1225051097) practices internal medicine in the Longview-Kelso, WA market, with the plurality of this provider's patient population coming from Cowlitz, WA. Richards uses personal NPI as billing NPI and primary practice location at 98632-2429.

Richards' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 192 traditional Medicare patients, billed 2,272 HCPCS/CPT codes, and received $95,931 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 5,215 prescription claims across 239 beneficiaries totaling $760,538 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 17 claims. Open Payments data shows 2 records totaling $143. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $453,331 to $760,538. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $8,124 to $4,860.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	300	1,853	$85,695
2016	283	1,772	$77,450
2017	278	2,028	$82,953
2018	265	1,942	$82,226
2019	252	1,750	$77,287
2020	226	1,588	$70,130
2021	224	1,624	$84,694
2022	218	1,827	$92,790
2023	200	1,655	$82,667
2024	192	2,272	$95,931

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	252	5,117	$453,331
2016	248	5,078	$403,230
2017	234	4,899	$401,704
2018	235	4,819	$457,985
2019	242	4,728	$456,863
2020	236	4,877	$511,059
2021	238	4,883	$575,311
2022	245	5,025	$654,639
2023	242	5,009	$766,323
2024	239	5,215	$760,538

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	19	113	$2,443
2016	40	143	$1,266
2017	32	115	$859
2018	14	62	$600
2019	12	32	$727
2020	12	55	$1,373
2021	N/R	38	$443
2022	N/R	64	$916
2023	N/R	18	$228
2024	N/R	17	$197

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	126	126	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	144	404	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	146	345	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	158	522	$12
36415	Insertion of needle into vein for collection of blood sample	180	536	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	158	4,660	$171,878
Eliquis	Apixaban	123	9,084	$166,981
Jardiance	Empagliflozin	28	2,470	$49,170
Ozempic	Semaglutide	30	1,210	$38,855
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	1,740	$37,292

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	17	$197

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$143	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John E. Richards, M.D.?

Tedicare shows public-source Medicare data for John E. Richards, M.D. (NPI 1225051097), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John E. Richards, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John E. Richards, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does John E. Richards, M.D. have Open Payments data?

John E. Richards, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.